Add to ORKG[[abstract]]The greatest change in the treatment of people living with type 1 diabetes in the last decade has been the explosion of technology assisting in all aspects of diabetes therapy, from glucose monitoring to insulin delivery and decision making. As such, the aim of our systematic review was to assess the utility of these technologies as well as identify any precision medicine-directed findings to personalize care
Introduction: Management and treatment of diabetes mellitus type 1 and diabetes mellitus type 2 have...
Funder: This research was funded by the National Institute of Health Research (NIHR) Cambridge Biome...
AbstractThis is the protocol of a systematic review that aims to explore outcomes relevant for peopl...
Background: Technology has been implemented since the 1970s with the hope of improving glycaemic con...
BACKGROUND: Technology has been implemented since the 1970s with the hope of improving glycaemic con...
Introduction: Diabetes monitoring systems (DMS) are a possible approach for regular control of gluco...
AIM: To summarize and evaluate the existing evidence on the effectiveness of distal technology with ...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Introduction Automated insulin delivery (AID), also known as artificial pancreas system or ‘closed-l...
Objective: To review published evidences about using information technology interventions in diabete...
BACKGROUND: Recent advances in information technology (IT) coupled with the increased ubiquitous nat...
Throughout the years monitoring and therapy of diabetes was significantly changing. Undoubtedly, a d...
Abstract Background The role of technology in the self-management of type 1 diabetes mellitus (T1DM)...
Type 1 diabetes (T1D) is a complex autoimmune disease that currently cannot be cured, only managed. ...
Abstract Background: Diabetes is a hormonal disorder that affects an estimated three hundred millio...
Introduction: Management and treatment of diabetes mellitus type 1 and diabetes mellitus type 2 have...
Funder: This research was funded by the National Institute of Health Research (NIHR) Cambridge Biome...
AbstractThis is the protocol of a systematic review that aims to explore outcomes relevant for peopl...
Background: Technology has been implemented since the 1970s with the hope of improving glycaemic con...
BACKGROUND: Technology has been implemented since the 1970s with the hope of improving glycaemic con...
Introduction: Diabetes monitoring systems (DMS) are a possible approach for regular control of gluco...
AIM: To summarize and evaluate the existing evidence on the effectiveness of distal technology with ...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Introduction Automated insulin delivery (AID), also known as artificial pancreas system or ‘closed-l...
Objective: To review published evidences about using information technology interventions in diabete...
BACKGROUND: Recent advances in information technology (IT) coupled with the increased ubiquitous nat...
Throughout the years monitoring and therapy of diabetes was significantly changing. Undoubtedly, a d...
Abstract Background The role of technology in the self-management of type 1 diabetes mellitus (T1DM)...
Type 1 diabetes (T1D) is a complex autoimmune disease that currently cannot be cured, only managed. ...
Abstract Background: Diabetes is a hormonal disorder that affects an estimated three hundred millio...
Introduction: Management and treatment of diabetes mellitus type 1 and diabetes mellitus type 2 have...
Funder: This research was funded by the National Institute of Health Research (NIHR) Cambridge Biome...
AbstractThis is the protocol of a systematic review that aims to explore outcomes relevant for peopl...